DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Bhamidimarri KR, Czul F, Peyton A et al.
Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease (vol 63, pg 763, 2015).
Journal of Hepatology 2015;
63: 1542-1542
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.